Please use this identifier to cite or link to this item:
Title: Structure-activity relationship studies of phenanthridine-based Bcl-X L inhibitors
Authors: Bernardo, P.H.
Wan, K.-F.
Sivaraman, T. 
Xu, J.
Moore, F.K.
Hung, A.W.
Mok, H.Y.K. 
Yu, V.C.
Chai, C.L.L.
Issue Date: 13-Nov-2008
Citation: Bernardo, P.H., Wan, K.-F., Sivaraman, T., Xu, J., Moore, F.K., Hung, A.W., Mok, H.Y.K., Yu, V.C., Chai, C.L.L. (2008-11-13). Structure-activity relationship studies of phenanthridine-based Bcl-X L inhibitors. Journal of Medicinal Chemistry 51 (21) : 6699-6710. ScholarBank@NUS Repository.
Abstract: Despite their structural similarities, the natural products chelerythrine (5) and sanguinarine (6) target different binding sites on the pro-survival Bcl-XL protein. This paper details the synthesis of phenanthridine-based analogues of the natural products that were used to probe this difference in binding profiles. The inhibitory constants for these compounds were then measured in a fluorescence polarization assay against Bcl-XL and the tagged Bak-BH3 peptide. The results led to structure-activity relationship studies, which identified the structural motifs required for binding-site specificity as well as inhibitory activity. We also identified synthetic analogues of the natural products that display similar binding modes but with more potent IC50 values. © 2008 American Chemical Society.
Source Title: Journal of Medicinal Chemistry
ISSN: 00222623
DOI: 10.1021/jm8005433
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on May 20, 2022


checked on May 20, 2022

Page view(s)

checked on May 12, 2022

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.